Avidian Wealth Enterprises LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 37.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 901 shares of the medical equipment provider’s stock after purchasing an additional 245 shares during the quarter. Avidian Wealth Enterprises LLC’s holdings in Intuitive Surgical were worth $470,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of the company. Great Lakes Retirement Inc. lifted its holdings in shares of Intuitive Surgical by 1.6% in the fourth quarter. Great Lakes Retirement Inc. now owns 3,215 shares of the medical equipment provider’s stock valued at $1,678,000 after buying an additional 50 shares during the period. Capital Advisors Inc. OK lifted its holdings in shares of Intuitive Surgical by 1.5% in the fourth quarter. Capital Advisors Inc. OK now owns 129,751 shares of the medical equipment provider’s stock valued at $67,725,000 after buying an additional 1,858 shares during the period. Certuity LLC lifted its holdings in shares of Intuitive Surgical by 45.3% in the fourth quarter. Certuity LLC now owns 1,932 shares of the medical equipment provider’s stock valued at $1,008,000 after buying an additional 602 shares during the period. Leavell Investment Management Inc. lifted its holdings in shares of Intuitive Surgical by 0.7% in the fourth quarter. Leavell Investment Management Inc. now owns 3,556 shares of the medical equipment provider’s stock valued at $1,856,000 after buying an additional 25 shares during the period. Finally, Portfolio Design Labs LLC lifted its holdings in shares of Intuitive Surgical by 14.7% in the fourth quarter. Portfolio Design Labs LLC now owns 4,035 shares of the medical equipment provider’s stock valued at $2,106,000 after buying an additional 516 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the company. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. BTIG Research increased their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Finally, Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.
Insider Buying and Selling at Intuitive Surgical
In other news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $591.39 on Friday. The stock has a fifty day moving average price of $557.70 and a two-hundred day moving average price of $517.49. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company has a market cap of $210.64 billion, a price-to-earnings ratio of 92.26, a PEG ratio of 5.67 and a beta of 1.39.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- How to invest in marijuana stocks in 7 steps
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- What Are Growth Stocks and Investing in Them
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Investing in the High PE Growth Stocks
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.